186 related articles for article (PubMed ID: 6688487)
1. [Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
Kolygin BA; Kharatishvili ZV
Vopr Onkol; 1983; 29(8):12-5. PubMed ID: 6688487
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
3. [Combined therapy of lymphogranulomatosis].
Vorob'ev AI; Fokina NT; Brilliant MD; Fil'kova EM
Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):3-7. PubMed ID: 6895412
[No Abstract] [Full Text] [Related]
4. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
5. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
6. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Klein HO
Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
[No Abstract] [Full Text] [Related]
8. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
9. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
Rahim MA; Sarma SK; Ahmed Q
Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
[No Abstract] [Full Text] [Related]
12. [Combined chemotherapy in Hodgkin's disease].
Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
[No Abstract] [Full Text] [Related]
13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
14. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
15. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
16. [Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
Marinone G; Maiolini E; Buttolo Q; Mauro PL; Colle R
Minerva Med; 1975 Apr; 66(31):1466-71. PubMed ID: 48218
[TBL] [Abstract][Full Text] [Related]
17. [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
Denz H; Lechleitner M; Peschel C; Peer L; Huber H
Wien Klin Wochenschr; 1983 May; 95(10):326-32. PubMed ID: 6688488
[TBL] [Abstract][Full Text] [Related]
18. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
19. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
20. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
